Back
KalVista Pharmaceuticals Stock Price Chart
Sponsored
KALV
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
58
KALV
KalVista Pharmaceuticals
Last Price:
11.23
Seasonality Move:
9.75%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.
KalVista Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.42 | Buy |
20-day SMA: | 11.65 | Sell |
50-day SMA: | 11.58 | Buy |
200-day SMA: | 12.41 | Sell |
8-day EMA: | 11.34 | Buy |
20-day EMA: | 11.51 | Buy |
50-day EMA: | 11.7 | Sell |
200-day EMA: | 11.83 | Sell |
KalVista Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 50.61 | Buy |
Chaikin Money Flow: | -197136 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
KalVista Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for KalVista Pharmaceuticals Stock
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 11.63 while KALV 8-day simple moving average is 11.42, which is a Buy signal.
- The stock price of KALV is 11.63 while KalVista Pharmaceuticals 20-day SMA is 11.65, which makes it a Sell.
- KalVista Pharmaceuticals 50-day simple moving average is 11.58 while KALV share price is 11.63, making it a Buy technically.
- KALV stock price is 11.63 and KalVista Pharmaceuticals 200-day simple moving average is 12.41, creating a Sell signal.
KALV Technical Analysis vs Fundamental Analysis
Buy
58
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy or a Sell?
-
KalVista Pharmaceuticals stock is rated a Buy
The current KalVista Pharmaceuticals [KALV] share price is $11.63. The Score for KALV is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
KalVista Pharmaceuticals Stock Info
Market Cap:
502.6M
Price in USD:
11.63
Share Volume:
755.36K
KalVista Pharmaceuticals 52-Week Range
52-Week High:
16.88
52-Week Low:
7.21
Buy
58
KalVista Pharmaceuticals (KALV)
is a Buy
KalVista Pharmaceuticals Share Price Forecast
-
What is the KalVista Pharmaceuticals stock price today?
The KalVista Pharmaceuticals stock price is 11.63 USD today. -
Will KALV stock go up or go down?
KalVista Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is KalVista Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, KalVista Pharmaceuticals is not overvalued.
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 11.63 while KALV 8-day exponential moving average is 11.34, which is a Buy signal.
- The stock price of KALV is 11.63 while KalVista Pharmaceuticals 20-day EMA is 11.51, which makes it a Buy.
- KalVista Pharmaceuticals 50-day exponential moving average is 11.70 while KALV share price is 11.63, making it a Sell technically.
- KALV stock price is 11.63 and KalVista Pharmaceuticals 200-day simple moving average is 11.83, creating a Sell signal.
Fundamental Analysis of KalVista Pharmaceuticals
Is KalVista Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and a decrease next year of $0.40 per share.
Technical Analysis of KalVista Pharmaceuticals
Should I short KalVista Pharmaceuticals stock?
- KALV Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting KalVista Pharmaceuticals is a Sell
- KalVista Pharmaceuticals Relative Strength Index (RSI) is 50.61, which suggest KalVista Pharmaceuticals is overbought
- The Bollinger Bands (25) for KalVista Pharmaceuticals is ( - ), which suggest KalVista Pharmaceuticals is a Buy
- The Bollinger Bands (100) for KalVista Pharmaceuticals is ( - ), which suggest KalVista Pharmaceuticals is a Buy
* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.